TickerFacts.

Kura Oncology, Inc. (KURA): Operating Income

Annual figures by period end, from SEC filings.

-$303.63M
Year ended 2025-12-31
-$318.09M
Trailing 12 months to 2026-06-30
2010-12-31: -$20.5K2011-12-31: -$23.4K2012-12-31: -$22.3K2013-12-31: -$22.7K2014-12-31: -$23.9K2022-12-31: -$139.87M2023-12-31: -$165.80M2024-12-31: -$193.19M2025-12-31: -$303.63M-$303.63M
2010-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$303.63Mn/m2026-03-05, From 2025-01-01
2024-12-31-$193.19Mn/m2026-03-05, From 2024-01-01
2023-12-31-$165.80Mn/m2026-03-05, From 2023-01-01
2022-12-31-$139.87Mn/a2025-02-28, From 2022-01-01
No annual figure between 2014-12-31 and 2022-12-31.
2014-12-31-$23.9Kn/m2015-02-27, From 2014-01-01
2013-12-31-$22.7Kn/m2015-02-27, From 2013-01-01
2012-12-31-$22.3Kn/m2014-03-31, From 2012-01-01
2011-12-31-$23.4Kn/m2013-03-28, From 2011-01-01
2010-12-31-$20.5Kn/a2012-03-30, From 2010-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Kura Oncology, Inc. (KURA)2025-12-31-$303.63Mn/m
Spero Therapeutics, Inc. (SPRO)2025-12-31$6.31Mn/m
Rockwell Medical, Inc. (RMTI)2025-12-31-$4.69Mn/m
Enanta Pharmaceuticals Inc (ENTA)2025-09-30-$85.35Mn/m
Viridian Therapeutics, Inc. (VRDN)2025-12-31-$363.39Mn/m
Fortress Biotech, Inc. (FBIO)2025-12-31-$70.22Mn/m
Assembly Biosciences, Inc. (ASMB)2025-12-31-$12.12Mn/m
Nuvation Bio Inc. (NUVB)2025-12-31-$213.06Mn/m
Bicycle Therapeutics PLC (BCYC)2025-12-31-$247.06Mn/m

Compare KURA, SPRO, RMTI, ENTA side by side · Screen every company in Pharmaceutical Preparations ↗